The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
"The Company announced on 1 June 2010 that it had entered into a long-term alliance with DSM to develop Fruitflow® in all major global markets, through an effective commercialisation of current formats and pioneering new and significant applications (the "Alliance"). Strategy, co-ordination, organisation and implementation for the Alliance is governed by an Alliance Board comprising two members from each partner company. The agreement extends initially until 2022 at which time the partners will review the arrangement. DSM will put substantial efforts into the Alliance and will be responsible for: manufacturing; marketing; and selling Fruitflow® via its substantial sales force. Provexis will be responsible for contributing scientific expertise necessary for the successful commercialisation of the product."
https://www.investegate.co.uk/provexis-plc--pxs-/rns/interim-results/201012160700080528Y/
Would like to be a fly on the wall during the review but any renegotiations should be in our favour IMO.
So much information on how good Fruitflow is. Even helps towards Covid-19 yet DSM still cant bag a major or Global. I am sure Bi-Health will do the business for us. Gixer, when is our deal with DSM ending
Not going to go through all FF products but this is what Zaax says.
"Healthy blood flow during the COVID-19 epidemic
The problems related to the COVID-19 epidemic concern not only the disease itself, but also other areas of the drowia, especially the cardiovascular system. Isolation, limited movement, less access to health care or tress, can negatively affect platelet aggregation and disrupt proper circulation .
Maintaining healthy blood flow during an epidemic is particularly important in those who may have been at risk of blood flow disorders before the pandemic, and in all healthy people who have had COVID-19 and all who are at risk of falling ill."
https://zaax.com.pl/
"During the COVID-19 epidemic, good blood flow should be ensured by the above-mentioned people and:
healthy people who have had COVID-19
all those who are at risk of falling ill"
https://sequoia.pl/product/zaax/
"Who is to say European products couldn't focus there advertising on maintaining normal platelet aggregation before or during initial or mild infection as a benefit of Fruitflow?"
should read
Who is to say European products couldn't focus there advertising on maintaining normal platelet aggregation before or during initial or mild infection as a potential benefit of Fruitflow?
Duttaroy says in his reply.
"The potential impact of the platelet in infection has only recently really come to the forefront of attention, and so although there are some studies currently in the planning stage, we do not have much to reference here yet."
Sounds like they are on the case.
alfista, "demonstrate that there is a long way to go before any health claim could be established" I don't disagree but all countries don't have such a stringent regulatory body as Europe or China.
AFC Life science in Indonesia, with there recent seminars, are obviously happy to make the health benefit connection to Fruitflow and Covid-19. Not only AFC but Biogrow with SmoFlo in Malaysia are also able to say that platelet aggregation due to Covid-19 could be reduced and help avoid unwanted blood clots with the use of Fruitflow.
https://biogrow.com.my/smoflo-capsule/trial-program
Its all above my pay grade but Fruitflow already has the health claim "Helps maintain normal platelet aggregation, which contributes to healthy blood flow" and Covid-19 has been proven to activate platelets and cause blood clots.
2+2=?
Who is to say European products couldn't focus there advertising on maintaining normal platelet aggregation before or during initial or mild infection as a benefit of Fruitflow?
Saying that, I doubt we will see it any time soon.
The reviewer's response, and replies to the reviewer, demonstrate that there is a long way to go before any health claim could be established. Set against this , seminars talking about the health claims have happened. If we are waiting for a new branch of Fruitflow benefits to be confirmed, the wait could be substantial IMHO. Better to concentrate on established claims for the time being.
wellsite, not sure what you mean by "presented" but it was first released as a "preprint"and not peer-reviewed April 2021.
https://www.preprints.org/manuscript/202104.0039/v1/download
Then published as a review paper in Nutrients journal: 25 June 2021
https://www.mdpi.com/2072-6643/13/7/2184/pdf
Peer-Review Record
https://www.mdpi.com/2072-6643/13/7/2184/review_report
Re "do you think PXS are in talks to sell up?"
No, raising a million in a placing doesn't square up with the idea of actively looking to sell up, quite the opposite.
Plainly if someone came along with a really good offer, that'd be something to consider, so never say never, but that's very different to actively looking to sell up
BB
gixer
more things to add to the Top Secret File
The new perspective paper is popping up all over the place. To the best of your knowledge has it been presented anywhere ?
W$
https://www.researchgate.net/publication/352733677_Dietary_Antiplatelets_A_New_Perspective_on_the_Health_Benefits_of_the_Water-Soluble_Tomato_Concentrate_Fruitflow_R
Can't remember if I have posted this one before.
"Fruitflow,a Water-soluble Tomato Extract,Regulates Platelet Oxidative Damage via Autophagy in Vitro"
http://kns55.en.eastview.com/KCMS/detail/detail.aspx?filename=ZSYK202103001&dbcode=CJFQ&dbname=CJFD2021
"?Conclusion?Fruitflow can significantly reduce the H2O2-induced platelet oxidative damage by promoting autophagy in vitro"
Hope springs eternal and darkest before dawn are the go to sayings to see you through here . Boringbernie do you think PXS are in talks to sell up?
Great news that Fruitflow is being highlighted in the context of being efficacious against Covid symptoms. Hopefully brands will be looking in to the seminar.
Doubt it will be in English but here is the link to the live stream.
https://www.facebook.com/watch/live/?v=360552749113392&ref=notif¬if_id=1627111799884440¬if_t=live_video
Another live seminar on Fruitflow and Covid-19 today. This time with dr. Yudhy Winata
https://www.facebook.com/LifeScience.co.id/posts/4167946273281464
Dear respected members, In connection with the joint health seminar *Prof. Asim K. Duttaroy, Ruedi Duss, and Taichi Inui with the title Fruitflow and its relation to Covid-19* which was held last week and received great enthusiasm from all members. So at the end of this week there will be an event similar to the Indonesian version. Health Seminar : *Fruitflow and its relationship with Covid-19 with dr. Yudhy Winata* will be held on *Saturday, July 24, 2021 at 15.00 WIB* This event is a full seminar (no company explanation and marketing plan) You can access this event via *ZOOM* and *FACEBOOK LIVE* on the *LIFE SCIENCE* page
bob, just remember to make a song & dance about the sp rising by 20+% on Monday. Which will also be fake news. Honestly, don't let the MM manipulations take you in or you've got no chance!
A former CEO got out at 7p. Good decision!
Agree Krusty, there is no change in the sp but we do seem to have had more than our fair share of Uncrossed Trades and Price Monitoring Extensions lately.
Seriously not looking good at all
10 years + ive been here ,the high 22p should have sold and now still less than than 1p
If you want to check it out look at the trades on the main page. Uncrossed trade (UT) at 16:45 yesterday printed at 0.95 (mid was c. 0.855). Another UT at 15:28 today printed at 0.755 (mid was c. 0.855). I have no idea why the mid price always shows the most recent A trade or UT but it does, for all shares, on all platforms.
This is pretty basic stuff to be honest...
DP64 there are lies, damn lies and false mid prices. Yesterday's close (0.94) was incorrect (should have been 0.855), the current mid price (0.76) is incorrect (should be 0.855). Basically the sp hasn't changed at all over the two days. So no need to panic. K
So, what is happening? Without any volume big drop?
Good news the beans have been counted for the day, day's task accomplished by DB.
Aaaaahhhhh, disappointment. The constant companion of PXS LTH's over the years. One day Rodney, you mark my words, one day!